How COVID-19 Emergency Use Authorizations Impacted the Provision of Medical Information
- Listeners will get a brief introduction to EUA
- Understand what measures were taken to prepare medical information to respond to customer requests for an EUA product from a resourcing and content perspective
- Understand unique opportunities to leverage new methods of delivery and channels for medical information in an EUA scenario
This webinar will feature speakers from Eli Lilly and Company, Gilead, and Pfizer. They will come together to represent their experiences in establishing medical information strategy, content and operations for Emergency Use Authorization (EUA) products for the prevention and treatment of COVID-19. Speakers will share their experiences readying their organizations to answer medical information inquiries from a resourcing, customer, and channels and scientific content perspective. They will discuss unique opportunities to partner both internally and externally to ensure customer information needs are met through a variety of channels. Finally, speakers will review what lessons they learned during their journeys.
MAPS members, please log in for immediate access:
Nonmembers, access this content in one of the following ways: